Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Hepatology (Baltimore, Md.)
|
June 7, 2017
A phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of nononcogenic receptor tyrosine kinases
Yannan Fan, Maria Arechederra, Sylvie Richelme, et al.
Journal of Hepatology
|
November 16, 2020
ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma
Maria Arechederra, Sehrish K Bazai, Ahmed Abdouni, et al.
Journal of Physiology and Biochemistry
|
September 21, 2024
Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression
Idoia Bilbao, Miriam Recalde, Fabrice Daian, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 8, 2021
Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance
Fabienne Lamballe, Fahmida Ahmad, Yaron Vinik, et al.
Genome Research
|
July 22, 2010
The ANISEED database: digital representation, formalization, and elucidation of a chordate developmental program
Olivier Tassy, Delphine Dauga, Fabrice Daian, et al.
Nature Biotechnology
|
March 11, 2008
Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE)
Eric W Deutsch, Catherine A Ball, Jules J Berman, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Hepatology (Baltimore, Md.)
|
June 7, 2017
A phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of nononcogenic receptor tyrosine kinases
Yannan Fan, Maria Arechederra, Sylvie Richelme, et al.
Journal of Hepatology
|
November 16, 2020
ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma
Maria Arechederra, Sehrish K Bazai, Ahmed Abdouni, et al.
Journal of Physiology and Biochemistry
|
September 21, 2024
Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression
Idoia Bilbao, Miriam Recalde, Fabrice Daian, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 8, 2021
Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance
Fabienne Lamballe, Fahmida Ahmad, Yaron Vinik, et al.
Genome Research
|
July 22, 2010
The ANISEED database: digital representation, formalization, and elucidation of a chordate developmental program
Olivier Tassy, Delphine Dauga, Fabrice Daian, et al.
Nature Biotechnology
|
March 11, 2008
Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE)
Eric W Deutsch, Catherine A Ball, Jules J Berman, et al.
Page
of 3